Grünenthal is a global leader in pain management.
Grünenthal is a global leader in pain management and related diseases. As a science-based, privately-owned pharmaceutical company, we have a long track record of bringing innovative treatments and state-of-the-art technologies to patients worldwide. We are focusing all of our activities and efforts on moving towards our vision of a World Free of Pain.
We are present in 28 countries with affiliates in Europe, Latin America, and the US.
Our products are sold in around 100 countries.
4,300 employees work for our group worldwide.

Annual Report 2024/25
Grünenthal has a clear, bold vision: a World Free of Pain. In 2024, we took big steps forward in developing innovative medicines for patients living with pain worldwide. The latest Grünenthal Report provides information about our key objectives and activities, as well as our recent business development highlights and financial performance.

Responsibility Report 2023

Pioneering thinkers

Careers
Ready to create a brighter future for our patients? With us, let your passion and ideas flow and drive innovation to improve our patients’ lives.
Join forces.
Make an impact.
Innovate for a world free of pain.
Work with Grünenthal